Drooid Logo
Back to today’s briefing

Story perspectives

FDA Approves TMS Therapy for Teens' Severe Depression

11/5/2025

33 6

1 of 1

Story summary
  • The U.S. Food and Drug Administration approved Transcranial Magnetic Stimulation (TMS) for severe depression in teens 15 and older.
  • It is a therapy using magnetic pulses to stimulate the brain for adolescents not responding to standard treatments.
  • The approval could expand insurance coverage as teen depression rises, since TMS typically requires 36 sessions.
  • Margaret Wilson, a local patient, said the approval could have significantly impacted her life if available earlier.